# 바이오스페이스 일일 뉴스 리포트 - 2025년 08월 08일


## 주요 헤드라인

1. **Novartis Continues Hunt for New Assets With Rumored Takeover of RNA Specialist Avidity (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novartis-continues-hunt-for-new-assets-with-rumored-takeover-of-rna-specialist-avidity>

2. **Novartis Continues Hunt for New Assets With Rumored Takeover of RNA Specialist Avidity (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novartis-continues-hunt-for-new-assets-with-rumored-takeover-of-rna-specialist-avidity>

3. **Lilly Faces Triple Threat of Drug Pricing Pressure as CEO Emphasizes Value (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-faces-triple-threat-of-drug-pricing-pressure-as-ceo-emphasizes-value>

4. **Lilly Faces Triple Threat of Drug Pricing Pressure as CEO Emphasizes Value (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-faces-triple-threat-of-drug-pricing-pressure-as-ceo-emphasizes-value>

5. **Big Pharma-Backed mRNA Startup Bags $153M Series B Amid Policy Headwinds (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/big-pharma-backed-mrna-startup-bags-153m-series-b-amid-policy-headwinds>

6. **UPDATE (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lillys-hotly-anticipated-oral-weight-loss-drug-delivers-lukewarm-results-in-phase-iii>

7. **Despite Safety Drama, Sarepta Beats Q2 Estimates—But No Thanks to Elevidys Sales (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/despite-safety-drama-sarepta-beats-q2-estimates-but-no-thanks-to-elevidys-sales>


---
*2025년 08월 08일 바이오스페이스 뉴스 피드에서 생성된 리포트*